目次

1 Report Overview
1.1 Introduction to Global Companion Diagnostics Market
1.2 Global Companion Diagnostics Market Definition
1.3 Why You Should Read This Report
1.4 What This Report Delivers
1.5 Key Questions Answered By This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Primary Research
1.7.2 Secondary Research
1.7.3 Market Evaluation & Forecasting Methodology
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Qualitative Analysis of the Global Companion Diagnostic Market
3.1 Market Dynamics
3.1.1 Drivers
3.1.1.1 Growing precedence of companion diagnostics over traditional practice of “one-size-fits-all” therapies
3.1.1.2 Accelerating demand for targeted therapy
3.1.1.3 Growing importance of personalized medicine to pave the way for companion diagnostic
3.1.1.4 Increasing global burden of cancer
3.1.1.5 Increase in scope of application of companion diagnostics
3.1.2 Restraints
3.1.2.1 High cost of developing companion diagnostic test to impede market growth
3.1.2.2 Challenges associated with uncertain reimbursement scenario in different regions
3.1.3 Opportunities
3.1.3.1 Upsurge in demand for next-generation sequencing based companion diagnostics
3.1.3.2 Growing significance of companion diagnostics as a powerful tool in drug discovery and development
3.1.3.3 Increasing number of clinical trials leading to inclusion of companion diagnostic
3.2 SWOT Analysis
3.3 PEST Analysis
3.3.1 Political
3.3.2 Economic
3.3.3 Sociocultural
3.3.4 Technological
3.4 Porter’s Five Forces Analysis
3.4.1 Moderate Bargaining Power of Supplier
3.4.2 High Bargaining Power of Buyer
3.4.3 Low Threat of New Entrants
3.4.4 High Threat of Substitutes
3.4.5 High Intensity of Competitive Rivalry
3.5 COVID-19 Impact Analysis
3.5.1 V-Shaped Recovery
3.5.2 U-Shaped Recovery
3.5.3 L-Shaped Recovery
3.5.4 W-Shaped Recovery

4 Global Companion Diagnostics Market, by Product & Services, 2021-2031
4.1 Global Companion Diagnostics Market Forecast by Product & Services, 2021-2031
4.2 Assays, Kits & Reagents
4.2.1 Increasing volume of CDX tests performed in laboratories to support the adoption of assays & kits
4.2.2 Global Companion Diagnostics Market for Assays, Kits & Reagents by Region: Market Forecast, 2021-2031
4.2.3 COVID-19 Impact on Global Companion Diagnostics Market Forecast for Assays, Kits & Reagents: Recovery Scenarios (V, U, W, L)
4.3 Software & Services
4.3.1 Need for effective data management software within laboratories to contribute to market growth.
4.3.2 Global Companion Diagnostics Market for Software & Services by Region: Market Forecast, 2021-2031
4.3.3 COVID-19 Impact on Global Companion Diagnostics Market Forecast for Software & Services: Recovery Scenarios (V, U, W, L)

5 Global Companion Diagnostics Market, by Technology, 2021-2031
5.1 Global Companion Diagnostics Market Forecast by Technology, 2021-2031
5.2 Polymerase Chain Reaction (PCR)
5.2.1 Growing applications of PCR technologies in personalized medicine and companion diagnostics to drive growth
5.2.2 Global Companion Diagnostics Market for Polymerase Chain Reaction (PCR) by Region: Market Forecast, 2021-2031
5.2.3 COVID-19 Impact on Global Companion Diagnostics Market For Polymerase Chain Reaction (PCR): Recovery Scenarios (V, U, W, L)
5.3 Next-Generation Sequencing (NSG)
5.3.1 Technological advancements and the high demand for NGS-based tests driving growth
5.3.2 Global Companion Diagnostics Market for Next-Generation Sequencing (NSG) by Region: Market Forecast, 2021-2031
5.3.3 COVID-19 Impact on Global Companion Diagnostics Market For Next-Generation Sequencing (NSG): Recovery Scenarios (V, U, W, L)
5.4 In Situ Hybridization (ISH)
5.4.1 Advancements in ISH and its demand in small-tumor diagnostics to drive growth
5.4.2 Global Companion Diagnostics Market for In Situ Hybridization (ISH) by Region: Market Forecast, 2021-2031
5.4.3 COVID-19 Impact on Global Companion Diagnostics Market For In Situ Hybridization (ISH): Recovery Scenarios (V, U, W, L)
5.5 Immunohistochemistry (IHC)
5.5.1 Increasing demand for user-friendly and cost-effective technologies in CDx to support growth in this segment
5.5.2 Global Companion Diagnostics Market for Immunohistochemistry (IHC) by Region: Market Forecast, 2021-2031
5.5.3 COVID-19 Impact on Global Companion Diagnostics Market For Immunohistochemistry (IHC): Recovery Scenarios (V, U, W, L)
5.6 Other Technologies
5.6.1 Global Companion Diagnostics Market for Other Technologies by Region: Market Forecast, 2021-2031
5.6.2 COVID-19 Impact on Global Companion Diagnostics Market For Other Technologies: Recovery Scenarios (V, U, W, L)

6 Global Companion Diagnostics Market, by Indication, 2021-2031
6.1 Global Companion Diagnostics Market Forecast by Indication, 2021-2031
6.2 Cancer
6.2.1 Breast cancer is the most common cancer among women which is a key factor contributing to the large share of this market segment
6.2.2 Global Companion Diagnostics Market for Cancer by Region: Market Forecast, 2021-2031
6.2.3 COVID-19 Impact on Global Companion Diagnostics Market For Cancer: Recovery Scenarios (V, U, W, L)
6.2.4 Breast Cancer
6.2.5 Lungs Cancer
6.2.6 Colorectal Cancer
6.2.7 Melanoma Cancer
6.2.8 Gastric Cancer
6.3 Infectious Disease
6.3.1 Growing focus of companion diagnostic players on orphan indications to propel the growth of this segment
6.3.2 Global Companion Diagnostics Market for Infectious Disease by Region: Market Forecast, 2021-2031
6.3.3 COVID-19 Impact on Global Companion Diagnostics Market For Infectious Disease: Recovery Scenarios (V, U, W, L)
6.4 Cardiovascular Diseases
6.4.1 Growing demand for targeted therapies due to high incidence of cardiovascular diseases to drive growth
6.4.2 Global Companion Diagnostics Market for Cardiovascular Diseases by Region: Market Forecast, 2021-2031
6.4.3 COVID-19 Impact on Global Companion Diagnostics Market For Cardiovascular Diseases: Recovery Scenarios (V, U, W, L)
6.5 Neurological Diseases
6.5.1 Growing number of diagnostic technologies for the treatment of neurological diseases to boost the adoption of companion diagnostics
6.5.2 Global Companion Diagnostics Market for Neurological Diseases by Region: Market Forecast, 2021-2031
6.5.3 COVID-19 Impact on Global Companion Diagnostics Market For Immunohistochemistry (IHC): Recovery Scenarios (V, U, W, L)
6.6 Other Indications
6.6.1 Global Companion Diagnostics Market for Other Indications by Region: Market Forecast, 2021-2031
6.6.2 COVID-19 Impact on Global Companion Diagnostics Market For Other Indications: Recovery Scenarios (V, U, W, L)

7 Global Companion Diagnostics Market, by End-User, 2021-2031
7.1 Global Companion Diagnostics Market Forecast by End-user, 2021-2031
7.2 Pharmaceutical & Biopharmaceutical Companies
7.2.1 Wide usage of CDx in pharmaceutical & biopharmaceutical companies to drive market growth
7.2.2 Global Companion Diagnostics Market for Pharmaceutical & Biopharmaceutical Companies by Region: Market Forecast, 2021-2031
7.2.3 COVID-19 Impact on Global Companion Diagnostics Market For Pharmaceutical & Biopharmaceutical Companies: Recovery Scenarios (V, U, W, L)
7.3 Reference Laboratories
7.3.1 Growing incidence of and rising demand for targeted therapies to drive growth
7.3.2 Global Companion Diagnostics Market for Reference Laboratories by Region: Market Forecast, 2021-2031
7.3.3 COVID-19 Impact on Global Companion Diagnostics Market For Reference Laboratories: Recovery Scenarios (V, U, W, L)
7.4 Contract Research Organizations (CRO)
7.4.1 CROs offer a complete range of companion diagnostic services to targeted therapy-related clinical trials
7.4.2 Global Companion Diagnostics Market for Contract Research Organizations (CRO) by Region: Market Forecast, 2021-2031
7.4.3 COVID-19 Impact on Global Companion Diagnostics Market For Contract Research Organizations (CRO): Recovery Scenarios (V, U, W, L)
7.5 Other End Users
7.5.1 Global Companion Diagnostics Market for Other End-User by Region: Market Forecast, 2021-2031
7.5.2 COVID-19 Impact on Global Companion Diagnostics Market For Other End-User: Recovery Scenarios (V, U, W, L)

8 Global Companion Diagnostics Market By Region, 2021-2031

9 North America Companion Diagnostics Market, 2021-2031
9.1.1 COVID-19 Impact on North America Companion Diagnostics Market: Recovery Scenarios (V, U, W, L)
9.2 North America Companion Diagnostics Market Forecast, by Product & Services, 2021-2031
9.3 North America Companion Diagnostics Market Forecast, by Technology, 2021-2031
9.4 North America Companion Diagnostics Market Forecast, by Indication, 2021-2031
9.5 North America Companion Diagnostics Market Forecast, by End User, 2021-2031
9.6 North America Companion Diagnostics Market Forecast, by Country, 2021-2031
9.7 US
9.7.1 US is the largest market for companion diagnostics largely driven by advanced diagnostic technologies, and increasing demand for molecular diagnostic-based personalized medicine.
9.7.2 Increasing funding from Federal Government
9.7.3 U.S. Companion Diagnostics Market Forecast, by Product & Services, 2021-2031
9.7.4 US Companion Diagnostics Market Forecast, by Technology, 2021-2031
9.7.5 US Companion Diagnostics Market Forecast, by Indication, 2021-2031
9.7.6 US Companion Diagnostics Market Forecast, by End User, 2021-2031
9.7.7 COVID-19 Impact on US Companion Diagnostics Market: Recovery Scenarios (V, U, W, L)
9.8 Canada
9.8.1 Rising incidence of chronic lifestyle diseases is expected to boost the market growth
9.8.2 Government initiatives to promote companion diagnostics in various indications to drive market growth in Canada.
9.8.3 Canada Companion Diagnostics Market Forecast, by Product & Services, 2021-2031
9.8.4 Canada Companion Diagnostics Market Forecast, by Technology, 2021-2031
9.8.5 Canada Companion Diagnostics Market Forecast, by Indication, 2021-2031
9.8.6 Canada Companion Diagnostics Market Forecast, by End User, 2021-2031
9.8.7 COVID-19 Impact on Canada Companion Diagnostics Market: Recovery Scenarios (V, U, W, L)

10 Europe Companion Diagnostics Market, 2021-2031
10.1.1 COVID-19 Impact on Europe Companion Diagnostics Market: Recovery Scenarios (V, U, W, L)
10.2 Europe Companion Diagnostics Market Forecast, by Product & Services, 2021-2031
10.3 Europe Companion Diagnostics Market Forecast, by Technology, 2021-2031
10.4 Europe Companion Diagnostics Market Forecast, by Indication, 2021-2031
10.5 Europe Companion Diagnostics Market Forecast, by End User, 2021-2031
10.6 Europe Companion Diagnostics Market Forecast, by Country, 2021-2031
10.7 Germany
10.7.1 Growing geriatric population and incidence of chronic disease will boost the market
10.7.2 Germany is a major market for pharmaceutical and biotechnology products.
10.7.3 Germany Companion Diagnostics Market Forecast, by Product & Services, 2021-2031
10.7.4 Germany Companion Diagnostics Market Forecast, by Technology, 2021-2031
10.7.5 Germany Companion Diagnostics Market Forecast, by Indication, 2021-2031
10.7.6 Germany Companion Diagnostics Market Forecast, by End User, 2021-2031
10.7.7 COVID-19 Impact on Germany Companion Diagnostics Market: Recovery Scenarios (V, U, W, L)
10.8 UK
10.8.1 Growth in the country’s life science industry is driving market growth in the UK.
10.8.2 Increasing R&D research will boost the market
10.8.3 UK Companion Diagnostics Market Forecast, by Product & Services, 2021-2031
10.8.4 UK Companion Diagnostics Market Forecast, by Technology, 2021-2031
10.8.5 UK Companion Diagnostics Market Forecast, by Indication, 2021-2031
10.8.6 UK Companion Diagnostics Market Forecast, by End User, 2021-2031
10.8.7 COVID-19 Impact on UK Companion Diagnostics Market: Recovery Scenarios (V, U, W, L)
10.9 Switzerland
10.9.1 Presence of large research-based pharmaceutical industry
10.9.2 Switzerland boasts a strong research oriented pharma industry, a key factor supporting market growth.
10.9.3 Switzerland Companion Diagnostics Market Forecast, by Product & Services, 2021-2031
10.9.4 Switzerland Companion Diagnostics Market Forecast, by Technology, 2021-2031
10.9.5 Switzerland Companion Diagnostics Market Forecast, by Indication, 2021-2031
10.9.6 Switzerland Companion Diagnostics Market Forecast, by End User, 2021-2031
10.9.7 COVID-19 Impact on Switzerland Companion Diagnostics Market: Recovery Scenarios (V, U, W, L)
10.10 France
10.10.1 Increasing government funding for genomics and personalized therapeutics R&D is driving market growth in France
10.10.2 Availability of reimbursement for cancer diagnostics
10.10.3 France Companion Diagnostics Market Forecast, by Product & Services, 2021-2031
10.10.4 France Companion Diagnostics Market Forecast, by Technology, 2021-2031
10.10.5 France Companion Diagnostics Market Forecast, by Indication, 2021-2031
10.10.6 France Companion Diagnostics Market Forecast, by End User, 2021-2031
10.10.7 COVID-19 Impact on France Companion Diagnostics Market: Recovery Scenarios (V, U, W, L)
10.11 Italy
10.11.1 Growing disease prevalence has contributed to the demand for better, more powerful therapeutics in Italy.
10.11.2 Economic slowdown of Italian healthcare industry
10.11.3 Italy Companion Diagnostics Market Forecast, by Product & Services, 2021-2031
10.11.4 Italy Companion Diagnostics Market Forecast, by Technology, 2021-2031
10.11.5 Italy Companion Diagnostics Market Forecast, by Indication, 2021-2031
10.11.6 Italy Companion Diagnostics Market Forecast, by End User, 2021-2031
10.11.7 COVID-19 Impact on Italy Companion Diagnostics Market: Recovery Scenarios (V, U, W, L)
10.12 Spain
10.12.1 Medical institutes in Spain are increasingly focusing on cancer biomarker research.
10.12.2 Presence of well-established network of research centers and healthcare organization
10.12.3 Spain Companion Diagnostics Market Forecast, by Product & Services, 2021-2031
10.12.4 Spain Companion Diagnostics Market Forecast, by Technology, 2021-2031
10.12.5 Spain Companion Diagnostics Market Forecast, by Indication, 2021-2031
10.12.6 Spain Companion Diagnostics Market Forecast, by End User, 2021-2031
10.12.7 COVID-19 Impact on Spain Companion Diagnostics Market: Recovery Scenarios (V, U, W, L)
10.13 Rest of Europe
10.13.1 Rest of Europe Companion Diagnostics Market Forecast, by Product & Services, 2021-2031
10.13.2 Rest of Europe Companion Diagnostics Market Forecast, by Technology, 2021-2031
10.13.3 Rest of Europe Companion Diagnostics Market Forecast, by Indication, 2021-2031
10.13.4 Rest of Europe Companion Diagnostics Market Forecast, by End User, 2021-2031
10.13.5 COVID-19 Impact on Rest of Europe Companion Diagnostics Market: Recovery Scenarios (V, U, W, L)

11 Asia-Pacific Companion Diagnostics Market, 2021-2031
11.1.1 COVID-19 Impact on Asia-Pacific Companion Diagnostics Market: Recovery Scenarios (V, U, W, L)
11.2 Asia-Pacific Companion Diagnostics Market Forecast, by Product & Services, 2021-2031
11.3 Asia-Pacific Companion Diagnostics Market Forecast, by Technology, 2021-2031
11.4 Asia-Pacific Companion Diagnostics Market Forecast, by Indication, 2021-2031
11.5 Asia-Pacific Companion Diagnostics Market Forecast, by End User, 2021-2031
11.6 Asia-Pacific Companion Diagnostics Market Forecast, by Country, 2021-2031
11.7 Japan
11.7.1 Japan holds the second largest share of the market in APAC majorly due to increasing demand for technologically advanced diagnostics.
11.7.2 Japan Companion Diagnostics Market Forecast, by Product & Services, 2021-2031
11.7.3 Japan Companion Diagnostics Market Forecast, by Technology, 2021-2031
11.7.4 Japan Companion Diagnostics Market Forecast, by Indication, 2021-2031
11.7.5 Japan Companion Diagnostics Market Forecast, by End User, 2021-2031
11.7.6 COVID-19 Impact on Japan Companion Diagnostics Market: Recovery Scenarios (V, U, W, L)
11.8 China
11.8.1 The country’s large annual R&D investments and technological capabilities is anticipated to drive growth.
11.8.2 High incidence of chronic diseases
11.8.3 China Companion Diagnostics Market Forecast, by Product & Services, 2021-2031
11.8.4 China Companion Diagnostics Market Forecast, by Technology, 2021-2031
11.8.5 China Companion Diagnostics Market Forecast, by Indication, 2021-2031
11.8.6 China Companion Diagnostics Market Forecast, by End User, 2021-2031
11.8.7 COVID-19 Impact on China Companion Diagnostics Market: Recovery Scenarios (V, U, W, L)
11.9 India
11.9.1 Government initiatives to tackle the growing burden of cancer and is expected to increase the adoption of CDX in the country.
11.9.2 Presence of large patient population
11.9.3 India Companion Diagnostics Market Forecast, by Product & Services, 2021-2031
11.9.4 India Companion Diagnostics Market Forecast, by Technology, 2021-2031
11.9.5 India Companion Diagnostics Market Forecast, by Indication, 2021-2031
11.9.6 India Companion Diagnostics Market Forecast, by End User, 2021-2031
11.9.7 COVID-19 Impact on India Companion Diagnostics Market: Recovery Scenarios (V, U, W, L)
11.10 Australia
11.10.1 Growing geriatric population in Australia has resulted in initiatives to enhance healthcare access and infrastructure.
11.10.2 Increase in initiative of government research funding
11.10.3 Australia Companion Diagnostics Market Forecast, by Product & Services, 2021-2031
11.10.4 Australia Companion Diagnostics Market Forecast, by Technology, 2021-2031
11.10.5 Australia Companion Diagnostics Market Forecast, by Indication, 2021-2031
11.10.6 Australia Companion Diagnostics Market Forecast, by End User, 2021-2031
11.10.7 COVID-19 Impact on Australia Companion Diagnostics Market: Recovery Scenarios (V, U, W, L)
11.11 Rest of APAC
11.11.1 Growing disease prevalence has contributed to the demand for better, more powerful therapeutics in Rest of APAC.
11.11.2 Rest of APAC Companion Diagnostics Market Forecast, by Product & Services, 2021-2031
11.11.3 Rest of APAC Companion Diagnostics Market Forecast, by Technology, 2021-2031
11.11.4 Rest of APAC Companion Diagnostics Market Forecast, by Indication, 2021-2031
11.11.5 Rest of APAC Companion Diagnostics Market Forecast, by End User, 2021-2031
11.11.6 COVID-19 Impact on Rest of APAC Companion Diagnostics Market: Recovery Scenarios (V, U, W, L)

12 Latin America, Middle East & Africa (LAMEA) Companion Diagnostics Market, 2021-2031
12.1.1 COVID-19 Impact on LAMEA Companion Diagnostics Market: Recovery Scenarios (V, U, W, L)
12.2 LAMEA Companion Diagnostics Market Forecast, by Product & Services, 2021-2031
12.3 LAMEA Companion Diagnostics Market Forecast, by Technology, 2021-2031
12.4 LAMEA Companion Diagnostics Market Forecast, by Indication, 2021-2031
12.5 LAMEA Companion Diagnostics Market Forecast, by End User, 2021-2031
12.6 LAMEA Companion Diagnostics Market Forecast, by Country, 2021-2031
12.7 Brazil
12.7.1 Increase in the adoption of new and advanced delivery technologies, including IVD products driving growth.
12.7.2 Increase in incidence of chronic disease
12.7.3 Brazil Companion Diagnostics Market Forecast, by Product & Services, 2021-2031
12.7.4 Brazil Companion Diagnostics Market Forecast, by Technology, 2021-2031
12.7.5 Brazil Companion Diagnostics Market Forecast, by Indication, 2021-2031
12.7.6 Brazil Companion Diagnostics Market Forecast, by End User, 2021-2031
12.7.7 COVID-19 Impact on Brazil Companion Diagnostics Market: Recovery Scenarios (V, U, W, L)
12.8 Mexico
12.8.1 Mexico is emerging as a prominent medical tourism hub.
12.8.2 Growing geriatric population
12.8.3 Mexico Companion Diagnostics Market Forecast, by Product & Services, 2021-2031
12.8.4 Mexico Companion Diagnostics Market Forecast, by Technology, 2021-2031
12.8.5 Mexico Companion Diagnostics Market Forecast, by Indication, 2021-2031
12.8.6 Mexico Companion Diagnostics Market Forecast, by End User, 2021-2031
12.8.7 COVID-19 Impact on Mexico Companion Diagnostics Market: Recovery Scenarios (V, U, W, L)
12.9 Rest of LAMEA
12.9.1 Government initiatives to tackle the growing burden of cancer are expected to increase the adoption of CDX in the country.
12.9.2 Rest of LAMEA Companion Diagnostics Market Forecast, by Product & Services, 2021-2031
12.9.3 Rest of LAMEA Companion Diagnostics Market Forecast, by Technology, 2021-2031
12.9.4 Rest of LAMEA Companion Diagnostics Market Forecast, by Indication, 2021-2031
12.9.5 Rest of LAMEA Companion Diagnostics Market Forecast, by End User, 2021-2031
12.9.6 COVID-19 Impact on Rest of LAMEA Companion Diagnostics Market: Recovery Scenarios (V, U, W, L)

13 Company Profiles
13.1 Market Share Analysis
13.1.1 Companion Diagnostic Market: Market Share Analysis, 2020
13.2 Roche Diagnostics
13.2.1 Company Overview
13.2.2 Company Snapshot
13.2.3 Product Portfolio
13.2.4 Financial Analysis
13.2.4.1 Net Revenue, 2016-2020
13.2.4.2 Segmental Revenue Shares, 2020
13.2.4.3 Regional Revenue Shares, 2020
13.2.5 Recent Developments, 2017-2020
13.3 Agilent Technologies Inc. (US)
13.3.1 Company Overview
13.3.2 Company Snapshot
13.3.3 Product Portfolio
13.3.4 Financial Analysis Net Revenue, 2016-2020
13.3.4.1 Segmental Revenue Shares, 2020
13.3.4.2 Regional Revenue Shares, 2020
13.3.5 Recent Developments, 2018-2020
13.4 QIAGEN N.V.
13.4.1 Company Overview
13.4.2 Company Snapshot
13.4.3 Product Portfolio
13.4.4 Financial Analysis
13.4.4.1 Net Revenue, 2016-2020
13.4.4.2 Segmental Revenue Shares, 2020
13.4.4.3 Regional Revenue Shares, 2020
13.4.5 Recent Developments, 2018-2020
13.5 Thermo Fisher Scientific, Inc.
13.5.1 Company Overview
13.5.2 Company Snapshot
13.5.3 Product Portfolio
13.5.4 Financial Analysis
13.5.4.1 Net Revenue, 2016-2020
13.5.4.2 Segmental Revenue Shares, 2020
13.5.4.3 Regional Revenue Shares, 2020
13.5.5 Recent Developments, 2017-2020
13.6 ABBOTT LABORATORIES
13.6.1 Company Overview
13.6.2 Company Snapshot
13.6.3 Product Portfolio
13.6.4 Financial Analysis
13.6.4.1 Net Revenue, 2016-2020
13.6.4.2 Segmental Revenue Shares, 2020
13.6.4.3 Regional Revenue Shares, 2020
13.6.5 Recent Developments, 2020
13.7 ALMAC GROUP
13.7.1 Company Overview
13.7.2 Company Snapshot
13.7.3 Product Portfolio
13.7.4 Financial Analysis
13.7.4.1 Net Revenue, 2018-2019
13.7.5 Recent Developments, 2019
13.8 DANAHER CORPORATION
13.8.1 Company Overview
13.8.2 Company Snapshot
13.8.3 Product Portfolio
13.8.4 Financial Analysis
13.8.4.1 Net Revenue, 2016-2020
13.8.4.2 Segmental Revenue Shares, 2020
13.8.4.3 Regional Revenue Shares, 2019
13.8.5 Recent Developments, 2020
13.9 ILLUMINA INC.
13.9.1 Company Overview
13.9.2 Company Snapshot
13.9.3 Product Portfolio
13.9.4 Financial Analysis
13.9.4.1 Net Revenue, 2016-2020
13.9.4.2 Regional Revenue Shares, 2020
13.9.5 Recent Developments, 2017-2019
13.10 BIOMERIEUX SA
13.10.1 Company Overview
13.10.2 Company Snapshot
13.10.3 Product Portfolio
13.10.4 Financial Analysis
13.10.4.1 Net Revenue, 2015-2019
13.10.4.2 Segmental Revenue Shares, 2019
13.10.4.3 Regional Revenue Shares, 2019
13.10.5 Recent Developments, 2020
13.11 MYRIAD GENETICS, INC.
13.11.1 Company Overview
13.11.2 Company Snapshot
13.11.3 Product Portfolio
13.11.4 Financial Analysis
13.11.4.1 Net Revenue, 2016-2020
13.11.4.2 Segmental Revenue Shares, 2020
13.11.5 Recent Developments, 2017-2020
13.12 SYSMEX CORPORATION
13.12.1 Company Overview
13.12.2 Company Snapshot
13.12.3 Product Portfolio
13.12.4 Financial Analysis
13.12.4.1 Net Revenue, 2015-2019
13.12.4.2 Segmental Revenue Shares, 2019
13.12.4.3 Regional Revenue Shares, 2019
13.12.5 Recent Developments, 2018-2020
13.13 GUARDANT HEALTH, INC.
13.13.1 Company Overview
13.13.2 Company Snapshot
13.13.3 Product Portfolio
13.13.4 Financial Analysis
13.13.4.1 Net Revenue, 2016-2019
13.13.4.2 Segmental Revenue Shares, 2019
13.13.4.3 Regional Revenue Shares, 2019
13.13.5 Recent Developments, 2017-2018
13.14 ICON PLC
13.14.1 Company Overview
13.14.2 Company Snapshot
13.14.3 Product Portfolio
13.14.4 Financial Analysis
13.14.4.1 Net Revenue, 2016-2020
13.14.4.2 Regional Revenue Shares, 2020
13.14.5 Recent Developments, 2018
13.15 ABNOVA CORPORATION
13.15.1 Company Overview
13.15.2 Company Snapshot
13.15.3 Product Portfolio
13.15.4 Recent Developments, 2017
13.16 BIOGENEX LABORATORIES, INC
13.16.1 Company Overview
13.16.2 Company Snapshot
13.16.3 Product Portfolio

14 Conclusion and Recommendations
14.1 Concluding Remarks from Visiongain
14.2 Recommendations for Market Players
14.3 Leading Regions and Fastest Growing Region (Crisp Tagline with Market

List of Tables
Table 2 Global Companion Diagnostic Market Forecast, 2021-2031 (US$ Bn, AGR%, CAGR%): "V" Shaped Recovery
Table 3 Global Companion Diagnostic Market Forecast, 2021-2031 (US$ Bn, AGR%, CAGR%): "U" Shaped Recovery
Table 4 Global Companion Diagnostic Market Forecast, 2021-2031 (US$ Bn, AGR%, CAGR%): "L" Shaped Recovery
Table 5 Global Companion Diagnostic Market Forecast, 2021-2031 (US$ Bn, AGR%, CAGR%): "W" Shaped Recovery
Table 1 Global Companion Diagnostics Market Forecast by Product & Services, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 2 Global Companion Diagnostics Market Forecast For Assays, Kits & Reagents by Region, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 3 Global Companion Diagnostics Market Forecast For Assays, Kits & Reagents, 2021-2031 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery
Table 4 Global Companion Diagnostics Market Forecast for Assays, Kits & Reagents, 2021-2031 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery
Table 5 Global Companion Diagnostics Market Forecast for Assays, Kits & Reagents, 2021-2031 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery
Table 6 Global Companion Diagnostics Market Forecast for Assays, Kits & Reagents, 2021-2031 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery
Table 7 Global Companion Diagnostics Market Forecast For Software & Services by Region, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 8 Global Companion Diagnostics Market Forecast For Software & Services, 2021-2031 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery
Table 9 Global Companion Diagnostics Market Forecast for Software & Services, 2021-2031 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery
Table 10 Global Companion Diagnostics Market Forecast for Software & Services, 2021-2031 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery
Table 11 Global Companion Diagnostics Market Forecast for Software & Services, 2021-2031 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery
Table 12 Global Companion Diagnostics Market Forecast by Technology, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 13 Global Companion Diagnostics Market Forecast For Polymerase Chain Reaction (PCR) by Region, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 14 Global Companion Diagnostics Market Forecast for Polymerase Chain Reaction (PCR), 2021-2031 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery
Table 15 Global Companion Diagnostics Market Forecast for Polymerase Chain Reaction (PCR), 2021-2031 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery
Table 16 Global Companion Diagnostics Market Forecast for Polymerase Chain Reaction (PCR), 2021-2031 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery
Table 17 Global Companion Diagnostics Market Forecast for Polymerase Chain Reaction (PCR), 2021-2031 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery
Table 18 Global Companion Diagnostics Market Forecast For Next-Generation Sequencing (NSG) by Region, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 19 Global Companion Diagnostics Market Forecast for Next-Generation Sequencing (NSG), 2021-2031 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery
Table 20 Global Companion Diagnostics Market Forecast for Next-Generation Sequencing (NSG), 2021-2031 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery
Table 21 Global Companion Diagnostics Market Forecast for Next-Generation Sequencing (NSG), 2021-2031 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery
Table 22 Global Companion Diagnostics Market Forecast for Next-Generation Sequencing (NSG), 2021-2031 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery
Table 23 Global Companion Diagnostics Market Forecast For In Situ Hybridization (ISH) by Region, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 24 Global Companion Diagnostics Market Forecast For In Situ Hybridization (ISH), 2021-2031 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery
Table 25 Global Companion Diagnostics Market Forecast For In Situ Hybridization (ISH), 2021-2031 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery
Table 26 Global Companion Diagnostics Market Forecast for In Situ Hybridization (ISH), 2021-2031 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery
Table 27 Global Companion Diagnostics Market Forecast for In Situ Hybridization (ISH), 2021-2031 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery
Table 28 Global Companion Diagnostics Market Forecast For Immunohistochemistry (IHC) by Region, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 29 Global Companion Diagnostics Market Forecast For Immunohistochemistry (IHC), 2021-2031 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery
Table 30 Global Companion Diagnostics Market Forecast For Immunohistochemistry (IHC), 2021-2031 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery
Table 31 Global Companion Diagnostics Market Forecast for Immunohistochemistry (IHC), 2021-2031 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery
Table 32 Global Companion Diagnostics Market Forecast for Immunohistochemistry (IHC), 2021-2031 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery
Table 33 Global Companion Diagnostics Market Forecast For Other Technologies by Region, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 34 Global Companion Diagnostics Market Forecast For Other Technologies, 2021-2031 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery
Table 35 Global Companion Diagnostics Market Forecast For Other Technologies, 2021-2031 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery
Table 36 Global Companion Diagnostics Market Forecast for Other Technologies, 2021-2031 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery
Table 37 Global Companion Diagnostics Market Forecast for Other Technologies, 2021-2031 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery
Table 38 Global Companion Diagnostics Market Forecast by Indication, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 39 Global Companion Diagnostics Market Forecast For Cancer by Region, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 40 Global Companion Diagnostics Market Forecast for Cancer, 2021-2031 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery
Table 41 Global Companion Diagnostics Market Forecast for Cancer, 2021-2031 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery
Table 42 Global Companion Diagnostics Market Forecast for Cancer, 2021-2031 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery
Table 43 Global Companion Diagnostics Market Forecast for Cancer, 2021-2031 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery
Table 44 Global Companion Diagnostics Market Forecast For Infectious Disease by Region, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 45 Global Companion Diagnostics Market Forecast for Infectious Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery
Table 46 Global Companion Diagnostics Market Forecast for Infectious Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery
Table 47 Global Companion Diagnostics Market Forecast for Infectious Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery
Table 48 Global Companion Diagnostics Market Forecast for Infectious Disease, 2021-2031 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery
Table 49 Global Companion Diagnostics Market Forecast For Cardiovascular Diseases by Region, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 50 Global Companion Diagnostics Market Forecast For Cardiovascular Diseases (ISH), 2021-2031 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery
Table 51 Global Companion Diagnostics Market Forecast For Cardiovascular Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery
Table 52 Global Companion Diagnostics Market Forecast for Cardiovascular Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery
Table 53 Global Companion Diagnostics Market Forecast for Cardiovascular Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery
Table 54 Global Companion Diagnostics Market Forecast For Neurological Diseases by Region, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 55 Global Companion Diagnostics Market Forecast For Neurological Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery
Table 56 Global Companion Diagnostics Market Forecast For Neurological Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery
Table 57 Global Companion Diagnostics Market Forecast for Neurological Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery
Table 58 Global Companion Diagnostics Market Forecast for Neurological Diseases, 2021-2031 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery
Table 59 Global Companion Diagnostics Market Forecast For Other Indications by Region, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 60 Global Companion Diagnostics Market Forecast For Other Indications, 2021-2031 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery
Table 61 Global Companion Diagnostics Market Forecast For Other Indications, 2021-2031 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery
Table 62 Global Companion Diagnostics Market Forecast for Other Technologies, 2021-2031 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery
Table 63 Global Companion Diagnostics Market Forecast for Other Technologies, 2021-2031 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery
Table 64 Global Companion Diagnostics Market Forecast by End-User, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 65 Global Companion Diagnostics Market Forecast For Pharmaceutical & Biopharmaceutical Companies by Region, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 66 Global Companion Diagnostics Market Forecast for Pharmaceutical & Biopharmaceutical Companies, 2021-2031 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery
Table 67 Global Companion Diagnostics Market Forecast for Pharmaceutical & Biopharmaceutical Companies, 2021-2031 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery
Table 68 Global Companion Diagnostics Market Forecast for Pharmaceutical & Biopharmaceutical Companies, 2021-2031 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery
Table 69 Global Companion Diagnostics Market Forecast for Pharmaceutical & Biopharmaceutical Companies, 2021-2031 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery
Table 70 Global Companion Diagnostics Market Forecast For Reference Laboratories by Region, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 71 Global Companion Diagnostics Market Forecast for Reference Laboratories, 2021-2031 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery
Table 72 Global Companion Diagnostics Market Forecast for Reference Laboratories, 2021-2031 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery
Table 73 Global Companion Diagnostics Market Forecast for Reference Laboratories, 2021-2031 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery
Table 74 Global Companion Diagnostics Market Forecast for Reference Laboratories, 2021-2031 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery
Table 75 Global Companion Diagnostics Market Forecast For Contract Research Organizations (CRO) by Region, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 76 Global Companion Diagnostics Market Forecast For Contract Research Organizations (CRO), 2021-2031 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery
Table 77 Global Companion Diagnostics Market Forecast For Contract Research Organizations (CRO), 2021-2031 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery
Table 78 Global Companion Diagnostics Market Forecast for Contract Research Organizations (CRO), 2021-2031 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery
Table 79 Global Companion Diagnostics Market Forecast for Contract Research Organizations (CRO), 2021-2031 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery
Table 80 Global Companion Diagnostics Market Forecast For Other End-User by Region, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 81 Global Companion Diagnostics Market Forecast For Other End-User, 2021-2031 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery
Table 82 Global Companion Diagnostics Market Forecast For Other End-User, 2021-2031 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery
Table 83 Global Companion Diagnostics Market Forecast for Other End-User, 2021-2031 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery
Table 84 Global Companion Diagnostics Market Forecast for Other End-User, 2021-2031 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery
Table 85 Global Companion Diagnostic Market Forecast by Region, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 86 North America Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR
Table 87 North America Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery
Table 88 North America Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery
Table 89 North America Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery
Table 90 North America Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery
Table 91 North America Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 92 North America Companion Diagnostics Market Forecast, by Technology, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 93 North America Companion Diagnostics Market Forecast, by Indication, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 94 North America Companion Diagnostics Market Forecast, by End User, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 95 North America Companion Diagnostics Market Forecast, by Country, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 96 US Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 97 US Companion Diagnostics Market Forecast, by Technology, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 98 US Companion Diagnostics Market Forecast, by Indication, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 99 US Companion Diagnostics Market Forecast, by End User, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 100 US Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “V” Shaped Recovery
Table 101 US Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “U” Shaped Recovery
Table 102 US Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery
Table 103 US Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “W” Shaped Recovery
Table 104 Canada Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 105 Canada Companion Diagnostics Market Forecast, by Technology, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 106 Canada Companion Diagnostics Market Forecast, by Indication, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 107 Canada Companion Diagnostics Market Forecast, by End User, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 108 Canada Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “V” Shaped Recovery
Table 109 Canada Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “U” Shaped Recovery
Table 110 Canada Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery
Table 111 Canada Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “W” Shaped Recovery
Table 112 Europe Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR
Table 113 Europe Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery
Table 114 Europe Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery
Table 115 Europe Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery
Table 116 Europe Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery
Table 117 Europe Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 118 Europe Companion Diagnostics Market Forecast, by Technology, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 119 Europe Companion Diagnostics Market Forecast, by Indication, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 120 Europe Companion Diagnostics Market Forecast, by End User, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 121 Europe Companion Diagnostics Market Forecast, by Country, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 122 Germany Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 123 Germany Companion Diagnostics Market Forecast, by Technology, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 124 Germany Companion Diagnostics Market Forecast, by Indication, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 125 Germany Companion Diagnostics Market Forecast, by End User, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 126 Germany Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “V” Shaped Recovery
Table 127 Germany Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “U” Shaped Recovery
Table 128 Germany Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery
Table 129 Germany Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “W” Shaped Recovery
Table 130 UK Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 131 UK Companion Diagnostics Market Forecast, by Technology, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 132 UK Companion Diagnostics Market Forecast, by Indication, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 133 UK Companion Diagnostics Market Forecast, by End User, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 134 UK Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “V” Shaped Recovery
Table 135 UK Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “U” Shaped Recovery
Table 136 UK Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery
Table 137 UK Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “W” Shaped Recovery
Table 138 Switzerland Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 139 Switzerland Companion Diagnostics Market Forecast, by Technology, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 140 Switzerland Companion Diagnostics Market Forecast, by Indication, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 141 Switzerland Companion Diagnostics Market Forecast, by End User, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 142 Switzerland Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “V” Shaped Recovery
Table 143 Switzerland Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “U” Shaped Recovery
Table 144 Switzerland Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery
Table 145 Switzerland Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “W” Shaped Recovery
Table 146 France Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 147 France Companion Diagnostics Market Forecast, by Technology, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 148 France Companion Diagnostics Market Forecast, by Indication, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 149 France Companion Diagnostics Market Forecast, by End User, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 150 France Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “V” Shaped Recovery
Table 151 France Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “U” Shaped Recovery
Table 152 France Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery
Table 153 France Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “W” Shaped Recovery
Table 154 Italy Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 155 Italy Companion Diagnostics Market Forecast, by Technology, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 156 Italy Companion Diagnostics Market Forecast, by Indication, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 157 Italy Companion Diagnostics Market Forecast, by End User, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 158 Italy Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “V” Shaped Recovery
Table 159 Italy Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “U” Shaped Recovery
Table 160 Italy Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery
Table 161 Italy Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “W” Shaped Recovery
Table 162 Spain Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 163 Spain Companion Diagnostics Market Forecast, by Technology, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 164 Spain Companion Diagnostics Market Forecast, by Indication, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 165 Spain Companion Diagnostics Market Forecast, by End User, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 166 Spain Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “V” Shaped Recovery
Table 167 Spain Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “U” Shaped Recovery
Table 168 Spain Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery
Table 169 Spain Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “W” Shaped Recovery
Table 170 Rest of Europe Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 171 Rest of Europe Companion Diagnostics Market Forecast, by Technology, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 172 Rest of Europe Companion Diagnostics Market Forecast, by Indication, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 173 Rest of Europe Companion Diagnostics Market Forecast, by End User, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 174 Rest of Europe Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “V” Shaped Recovery
Table 175 Rest of Europe Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “U” Shaped Recovery
Table 176 Rest of Europe Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery
Table 177 Rest of Europe Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “W” Shaped Recovery
Table 178 Asia-Pacific Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR
Table 179 Asia-Pacific Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery
Table 180 Asia-Pacific Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery
Table 181 Asia-Pacific Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery
Table 182 Asia-Pacific Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery
Table 183 Asia-Pacific Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 184 Asia-Pacific Companion Diagnostics Market Forecast, by Technology, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 185 Asia-Pacific Companion Diagnostics Market Forecast, by Indication, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 186 Asia-Pacific Companion Diagnostics Market Forecast, by End User, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 187 Asia-Pacific Companion Diagnostics Market Forecast, by Country, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 188 Japan Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 189 Japan Companion Diagnostics Market Forecast, by Technology, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 190 Japan Companion Diagnostics Market Forecast, by Indication, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 191 Japan Companion Diagnostics Market Forecast, by End User, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 192 Japan Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “V” Shaped Recovery
Table 193 Japan Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “U” Shaped Recovery
Table 194 Japan Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery
Table 195 Japan Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “W” Shaped Recovery
Table 196 China Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 197 China Companion Diagnostics Market Forecast, by Technology, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 198 China Companion Diagnostics Market Forecast, by Indication, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 199 China Companion Diagnostics Market Forecast, by End User, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 200 China Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “V” Shaped Recovery
Table 201 China Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “U” Shaped Recovery
Table 202 China Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery
Table 203 China Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “W” Shaped Recovery
Table 204 India Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 205 India Companion Diagnostics Market Forecast, by Technology, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 206 India Companion Diagnostics Market Forecast, by Indication, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 207 India Companion Diagnostics Market Forecast, by End User, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 208 India Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “V” Shaped Recovery
Table 209 India Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “U” Shaped Recovery
Table 210 India Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery
Table 211 India Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “W” Shaped Recovery
Table 212 Australia Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 213 Australia Companion Diagnostics Market Forecast, by Technology, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 214 Australia Companion Diagnostics Market Forecast, by Indication, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 215 Australia Companion Diagnostics Market Forecast, by End User, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 216 Australia Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “V” Shaped Recovery
Table 217 Australia Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “U” Shaped Recovery
Table 218 Australia Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery
Table 219 Australia Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “W” Shaped Recovery
Table 220 Rest of APAC Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 221 Rest of APAC Companion Diagnostics Market Forecast, by Technology, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 222 Rest of APAC Companion Diagnostics Market Forecast, by Indication, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 223 Rest of APAC Companion Diagnostics Market Forecast, by End User, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 224 Rest of APAC Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “V” Shaped Recovery
Table 225 Rest of APAC Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “U” Shaped Recovery
Table 226 Rest of APAC Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery
Table 227 Rest of APAC Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “W” Shaped Recovery
Table 228 LAMEA Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR
Table 229 LAMEA Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery
Table 230 LAMEA Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery
Table 231 LAMEA Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery
Table 232 LAMEA Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery
Table 233 LAMEA Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 234 LAMEA Companion Diagnostics Market Forecast, by Technology, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 235 LAMEA Companion Diagnostics Market Forecast, by Indication, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 236 LAMEA Companion Diagnostics Market Forecast, by End User, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 237 LAMEA Companion Diagnostics Market Forecast, by Country, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 238 Brazil Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 239 Brazil Companion Diagnostics Market Forecast, by Technology, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 240 Brazil Companion Diagnostics Market Forecast, by Indication, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 241 Brazil Companion Diagnostics Market Forecast, by End User, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 242 Brazil Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “V” Shaped Recovery
Table 243 Brazil Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “U” Shaped Recovery
Table 244 Brazil Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery
Table 245 Brazil Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “W” Shaped Recovery
Table 246 Mexico Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 247 Mexico Companion Diagnostics Market Forecast, by Technology, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 248 Mexico Companion Diagnostics Market Forecast, by Indication, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 249 Mexico Companion Diagnostics Market Forecast, by End User, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 250 Mexico Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “V” Shaped Recovery
Table 251 Mexico Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “U” Shaped Recovery
Table 252 Mexico Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery
Table 253 Mexico Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “W” Shaped Recovery
Table 254 Rest of LAMEA Companion Diagnostics Market Forecast, by Product & Services, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 255 Rest of LAMEA Companion Diagnostics Market Forecast, by Technology, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 256 Rest of LAMEA Companion Diagnostics Market Forecast, by Indication, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 257 Rest of LAMEA Companion Diagnostics Market Forecast, by End User, 2021-2031 (US$ Mn, AGR%, CAGR%)
Table 258 Rest of LAMEA Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “V” Shaped Recovery
Table 259 Rest of LAMEA Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “U” Shaped Recovery
Table 260 Rest of LAMEA Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “L” Shaped Recovery
Table 261 Rest of LAMEA Companion Diagnostics Market Forecast, 2021-2031 (US$ Mn, AGR%, CAGR%): “W” Shaped Recovery
?

List of Figures
Figure 1 Global Companion Diagnostics Market: SWOT Analysis
Figure 2 Moderate Bargaining Power of Supplier
Figure 3 High Bargaining Power of Buyer
Figure 4 Low Threat of New Entrants
Figure 5 Low Threat of Substitutes
Figure 6 High Intensity Of Competitive Rivalry
Figure 7 COVID-19 Impact on Companion Diagnostics Market (USD Billion), 2019-2031: V-Shaped Recovery
Figure 8 COVID-19 Impact on Companion Diagnostics Market (USD Billion), 2019-2031: U-Shaped Recovery
Figure 9 COVID-19 Impact on Companion Diagnostics Market (USD Billion), 2019-2031: L-Shaped Recovery
Figure 10 COVID-19 Impact on Companion Diagnostics Market (USD Billion), 2019-2031: W-Shaped Recovery
Figure 52 Global Companion Diagnostics Market Forecast by Region 2021-2031 (US$ billion)
Figure 53 Global Companion Diagnostic Market Share Forecast by Region 2021, 2026, 2031 (%)
Figure 54 North America Companion Diagnostics Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 55 COVID-19 Impact on North America Companion Diagnostics Market (USD Million), 2019-2031: V-Shaped Recovery
Figure 56 COVID-19 Impact on North America Companion Diagnostics Market (USD Million), 2019-2031: U-Shaped Recovery
Figure 57 COVID-19 Impact on North America Companion Diagnostics Market (USD Million), 2019-2031: L-Shaped Recovery
Figure 58 COVID-19 Impact on North America Companion Diagnostics Market (USD Million), 2019-2031: W-Shaped Recovery
Figure 60 North America Companion Diagnostics Market Share Forecast, by Product& Services, 2021 and 2031 (%)
Figure 62 North America Companion Diagnostics Market Share Forecast by Technology, 2020, 2026, 2031 (%)
Figure 64 North America Companion Diagnostics Market Share Forecast by Indication, 2020, 2026, 2031 (%)
Figure 66 North America Companion Diagnostics Market Share Forecast by End User, 2020, 2026, 2031 (%)
Figure 68 North America Companion Diagnostics Market Share Forecast by Country, 2020, 2026, 2031 (%)
Figure 69 US Companion Diagnostics Market Share Forecast, by Product & Services, 2020, 2026, 2031 (%)
Figure 70 US Companion Diagnostics Market Share Forecast by Technology, 2020, 2026, 2031 (%)
Figure 71 US Companion Diagnostics Market Share Forecast by Indication, 2020, 2026, 2031 (%)
Figure 72 US Companion Diagnostics Market Share Forecast by End User, 2020, 2026, 2031 (%)
Figure 73 COVID-19 Impact on US Companion Diagnostics Market (USD Million), 2019-2031: V-Shaped Recovery
Figure 74 COVID-19 Impact on US Companion Diagnostics Market (USD Million), 2019-2031: U-Shaped Recovery
Figure 75 COVID-19 Impact on US Companion Diagnostics Market (USD Million), 2019-2031: L-Shaped Recovery
Figure 76 COVID-19 Impact on US Companion Diagnostics Market (USD Million), 2019-2031: W-Shaped Recovery
Figure 77 Canada Companion Diagnostics Market Share Forecast, by Product & Services, 2020, 2026, 2031 (%)
Figure 78 Canada Companion Diagnostics Market Share Forecast by Technology, 2020, 2026, 2031 (%)
Figure 79 Canada Companion Diagnostics Market Share Forecast by Indication, 2020, 2026, 2031 (%)
Figure 80 Canada Companion Diagnostics Market Share Forecast by End User, 2020, 2026, 2031 (%)
Figure 81 COVID-19 Impact on Canada Companion Diagnostics Market (USD Million), 2019-2031: V-Shaped Recovery
Figure 82 COVID-19 Impact on Canada Companion Diagnostics Market (USD Million), 2019-2031: U-Shaped Recovery
Figure 83 COVID-19 Impact on Canada Companion Diagnostics Market (USD Million), 2019-2031: L-Shaped Recovery
Figure 84 COVID-19 Impact on Canada Companion Diagnostics Market (USD Million), 2019-2031: W-Shaped Recovery
Figure 85 Europe Companion Diagnostics Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 86 COVID-19 Impact on Europe Companion Diagnostics Market (USD Million), 2019-2031: V-Shaped Recovery
Figure 87 COVID-19 Impact on Europe Companion Diagnostics Market (USD Million), 2019-2031: U-Shaped Recovery
Figure 88 COVID-19 Impact on Europe Companion Diagnostics Market (USD Million), 2019-2031: L-Shaped Recovery
Figure 89 COVID-19 Impact on Europe Companion Diagnostics Market (USD Million), 2019-2031: W-Shaped Recovery
Figure